Advertisement

Treatment of Extraocular Retinoblastoma

Chapter
Part of the Essentials in Ophthalmology book series (ESSENTIALS)

Abstract

Retinoblastoma is the most common primary eye tumor in children worldwide. The presentation of disease in higher-income countries is almost universally intraocular in nature with highly favorable survival rates. This is due in part to the availability of multi-modality treatment options including enucleation, chemotherapy, local therapies, and external beam radiation therapy. In contrast, retinoblastoma most commonly presents as extraocular disease in lower-income nations often with poor prognostic outcomes. This chapter reviews the diagnosis and management options for the various stages of extraocular retinoblastoma.

In order to effectively standardize care for the treatment of retinoblastoma, an international staging system was proposed in 2006 as a consensus document. The authors of this chapter recommend that the classification of extraocular disease proposed in this system be used. In this system, stage II corresponds to microscopic residual tumor after eye enucleation. Stage III describes regional extension, including overt orbital disease or preauricular or cervical lymph node extension. Stage IV comprises metastatic disease with and without central nervous system extension (stages IVb and IVa disease, respectively).

This chapter describes the treatment options described in the scientific literature for treatment of the various stages of extraocular disease. Publications from multiple international groups have validated that patients with stage II or III disease can be cured with a combination of conventional, systemic chemotherapy, and external beam radiation therapy. By contrast, patients with stage IVa and IVb disease have poor outcomes when treated with similar protocols. However, when treatment is intensified to include high-dose chemotherapy followed by autologous stem cell rescue, there is potential for cure in patients with metastatic disease.

Keywords

Bone Marrow Disease Autologous Stem Cell Rescue Orbital Disease Intraocular Retinoblastoma Optic Nerve Infiltration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Compliance with Ethical Requirements

Ratna Behal, M.D. declares that she has no conflict of interest. Ira Dunkel declares no conflict of interest regarding the content of this chapter, but has had some consulting agreements with pharmaceutical companies.

No human or animal studies were carried out by the authors for this article.

References

  1. Antoneli CB, et al. Extraocular retinoblastoma: a 13-year experience. Cancer. 2003;98(6):1292–8.CrossRefPubMedGoogle Scholar
  2. Chantada G, et al. Treatment of overt extraocular retinoblastoma. Med Pediatr Oncol. 2003;40(3):158–61.CrossRefPubMedGoogle Scholar
  3. Chantada GL, et al. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy? Br J Ophthalmol. 2004;88(8):1069–73.CrossRefPubMedCentralPubMedGoogle Scholar
  4. Chantada G, et al. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer. 2006;47(6):801–5.CrossRefPubMedGoogle Scholar
  5. Children’s Oncology Group. A Trial of Intensive Multi-Modality Therapy for Extra-Ocular Retinoblastoma. National Institutes of Health. 2007. http://www.clinicaltrials.gov/ct2/show/study/NCT00554788?term=ARET0321&rank=1. Accessed 14 Oct 2014.
  6. de Jong MC, et al. Trilateral retinoblastoma: a systematic review and meta-analysis. Lancet Oncol. 2014;15:1157–67.CrossRefPubMedGoogle Scholar
  7. Doz F, et al. The role of chemotherapy in orbital involvement of retinoblastoma. The experience of a single institution with 33 patients. Cancer. 1994;74(2):722–32.CrossRefPubMedGoogle Scholar
  8. Dunkel IJ, et al. High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma. Pediatr Blood Cancer. 2010a;55(1):149–52.PubMedGoogle Scholar
  9. Dunkel IJ, et al. Trilateral retinoblastoma: potentially curable with intensive chemotherapy. Pediatr Blood Cancer. 2010b;54(3):384–7.CrossRefPubMedGoogle Scholar
  10. Dunkel IJ, et al. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma. Pediatr Blood Cancer. 2010c;55(1):55–9.PubMedGoogle Scholar
  11. Jubran RF, et al. Approaches to treatment for extraocular retinoblastoma: Children’s Hospital Los Angeles experience. J Pediatr Hematol Oncol. 2004;26(1):31–4.CrossRefPubMedGoogle Scholar
  12. Kremens B, et al. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma. Bone Marrow Transplant. 2003;31(4):281–4.CrossRefPubMedGoogle Scholar
  13. Matsubara H, et al. A multidisciplinary treatment strategy that includes high-dose chemotherapy for metastatic retinoblastoma without CNS involvement. Bone Marrow Transplant. 2005;35(8):763–6.CrossRefPubMedGoogle Scholar
  14. Namouni F, et al. High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study. Eur J Cancer. 1997;33(14):2368–75.CrossRefPubMedGoogle Scholar
  15. Rodriguez-Galindo C, et al. Treatment of metastatic retinoblastoma. Ophthalmology. 2003;110(6):1237–40.CrossRefPubMedGoogle Scholar
  16. Schvartzman E, et al. Results of a stage-based protocol for the treatment of retinoblastoma. J Clin Oncol. 1996;14(5):1532–6.PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Department of PediatricsMemorial Sloan Kettering Cancer CenterNew YorkUSA

Personalised recommendations